Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rojin Farzaneh, Alireza Khabbazi, Mohammad Sadegh Soltani-Zangbar, Samaneh Abbasian, Aida Malek Mahdavi, Roza Motavalli & Mehdi Yousefi. (2022) Effects of nanocurcumin supplementation on T‐helper 17 cells inflammatory response in patients with Behcet’s disease: a randomized controlled trial. Immunopharmacology and Immunotoxicology 44:2, pages 206-215.
Read now
Read now
Aida Malek Mahdavi, Alireza Khabbazi & Mehrzad Hajialilo. (2021) Long-term outcome and predictors of remission in Behçet’s disease in daily practice. Modern Rheumatology 31:6, pages 1148-1157.
Read now
Read now
Aida Malek Mahdavi, Alireza Khabbazi, Barmak Yaaghoobian, Morteza Ghojazadeh, Ramin Agamohammadi, Atefeh Kheyrollahiyan & Nadereh Rashtchizadeh. (2019) Cigarette smoking and risk of Behcet’s disease: a propensity score matching analysis. Modern Rheumatology 29:4, pages 633-639.
Read now
Read now
Articles from other publishers (28)
Maria Vincenza Mastrolia, Alessandra Bettiol, Edoardo Marrani, Ilaria Maccora, Emilia Taddei, Ilaria Pagnini, Maria Canfora, Giacomo Emmi, Elena Silvestri, Domenico Prisco & Gabriele Simonini. (2023) Behçet syndrome in children and adults: discovering similarities and differences by a comparative study. Rheumatology 62:SI2, pages SI189-SI195.
Crossref
Crossref
Alessandra Bettiol, Fatma Alibaz-Oner, Haner Direskeneli, Gulen Hatemi, David Saadoun, Emire Seyahi, Domenico Prisco & Giacomo Emmi. (2022) Vascular Behçet syndrome: from pathogenesis to treatment. Nature Reviews Rheumatology 19:2, pages 111-126.
Crossref
Crossref
Sevda Musavian, Rojin Farzaneh, Mehran Rahimi, Aida Malek Mahdavi, Morteza Gojazadeh & Alireza Khabbazi. (2022) Validity and reliability of the BODI for assessing damage in Behcet’s disease. Irish Journal of Medical Science (1971 -).
Crossref
Crossref
Amir Hossein Faghfouri, Behzad Baradaran, Alireza Khabbazi, Mahdi Abdoli Shadbad, Shahab Papi, Elnaz Faghfuri, Yaser Khajebishak, Shima Rahmani, Parastoo Tolou Hayat & Beitullah Alipour. (2022) Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial. International Immunopharmacology 109, pages 108825.
Crossref
Crossref
Alireza Khabbazi, Ali Reza Shafiee-Kandjani, Hadise Kavandi, Morteza Asadi & Maryam Panahzadeh. (2022) The Effect of Behcet’s Disease on Female and Male Sexual Functions. Iranian Journal of Psychiatry and Behavioral Sciences 16:2.
Crossref
Crossref
Amir Hossein Faghfouri, Alireza Khabbazi, Behzad Baradaran, Yaser Khajebishak, Elham Baghbani, Saeed Noorolyai, Shima Rahmani, Seyyed Morteza Seyyed Shoura, Maedeh Alipour & Beitullah Alipour. (2022) Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trial. Clinical Nutrition 41:5, pages 1083-1092.
Crossref
Crossref
Maryam Masoumi, Soraya Shadmanfar, Fereydoun Davatchi, Farhad Shahram, Massoomeh Akhlagi, Tahereh Faezi, Hoda Kavosi, Soroush Moradi & Javad Balasi. (2020) Correlation of clinical signs and symptoms of Behçet’s disease with mean platelet volume (MPV) and red cell distribution width (RDW). Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Sousan Kolahi, Nadereh Rashtchizadeh, Aida Malek Mahdavi, Jafar Farhadi, Alireza Khabbazi, Ebrahim Sakhinia, Neda Bahavarnia, Mohammad Jahed Farajzadeh Polsangi, Zohreh Babaloo & Mehrdad A. Estiar. (2020) Evaluation of DNA methylation status of toll‐like receptors 2 and 4 promoters in Behcet's disease. The Journal of Gene Medicine 22:10.
Crossref
Crossref
Shahin Asadi, Alireza Khabbazi, Shahriar Alipour, Somayeh Abolhasani, Jafar Haji, Hossein Amjadi & Ebrahim Sakhinia. (2020) Promoter methylation of Bax and Bcl2 genes and their expression in patients with Behcet’s disease. International Journal of Immunogenetics 47:3, pages 309-317.
Crossref
Crossref
Ezgi Deniz Batu & Seza Ozen. (2020) Measuring Vasculitis with Numbers: Outcome Scores. Current Rheumatology Reviews 16:1, pages 21-28.
Crossref
Crossref
Golamreza Jadideslam, Houman Kahroba, Khalil Ansarin, Ebrahim Sakhinia, Alireza Abhar, Shahriar Alipour, Jafar Farhadi, Sam Seydi Shirvani, Masoud Nouri-Vaskeh, Saeed Mousavi & Alireza khabbazi. (2020) Interleukin-17 mRNA expression and serum levels in Behçet’s disease. Cytokine 127, pages 154994.
Crossref
Crossref
Gonca Mumcu, Yusuf Yazici & Gulen Hatemi. 2020. Behçet Syndrome. Behçet Syndrome
261
278
.
Sam Seydi Shirvani, Mohammad Nouri, Ebrahim Sakhinia, Zohreh Babaloo, Golamreza jadideslam, Alipour Shahriar, Jafar Farhadi & Alireza khabbazi. (2019) The expression and methylation status of vitamin D receptor gene in Behcet's disease. Immunity, Inflammation and Disease 7:4, pages 308-317.
Crossref
Crossref
Golamreza Jadideslam, Khalil Ansarin, Ebrahim Sakhinia, Zohreh Babaloo, Alireza Abhari, Shahriar Alipour, Jafar Farhadi, Sam S Shirvani, Morteza Ghojazadeh & Alireza Khabbazi. (2019) Expression levels of miR-21, miR-146b and miR-326 as potential biomarkers in Behcet's disease. Biomarkers in Medicine 13:16, pages 1339-1348.
Crossref
Crossref
Masoud Nouri-Vaskeh, Aida Malek Mahdavi, Alireza Khabbazi & Golamreza Jadideslam. (2019) Lack of association between serum IL-9 levels and Behçet’s disease. Immunology Letters 211, pages 23-27.
Crossref
Crossref
Majid Ahmadi, Mehdi Yousefi, Sanaz Abbaspour‐Aghdam, Sanam Dolati, Leili Aghebati-Maleki, Shadi Eghbal‐Fard, Alireza Khabbazi, Davood Rostamzadeh, Shahriar Alipour, Mahdi Shabani, Mohammad Nouri & Zohreh Babaloo. (2018) Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet’s disease. Journal of Cellular Physiology 234:4, pages 3985-3994.
Crossref
Crossref
Sousan Kolahi, Mohammad-Jahed Farajzadeh, Shahriar Alipour, Alireza Abhari, Jafar Farhadi, Neda Bahavarnia, Aida Malek Mahdavi, Alireza Khabbazi & Ebrahim Sakhinia. (2018) Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-α and CTLA4 genes in patients with Behcet’s disease. Immunology Letters 204, pages 55-59.
Crossref
Crossref
Alireza Khabbazi, Hamid Noshad, Farid K. Shayan, Hadise Kavandi, Mehrzad Hajialiloo & Sousan Kolahi. (2014) Demographic and clinical features of Behcet's disease in Azerbaijan. International Journal of Rheumatic Diseases 21:5, pages 1114-1119.
Crossref
Crossref
Babak Afkari, Zohreh Babaloo, Sanam Dolati, Alireza Khabazi, Farhad Jadidi-Niaragh, Mahsa Talei, Dariush Shanehbandi, Shiva Mahmoudi, Bita Hazhirkarzar & Ebrahim Sakhinia. (2018) Molecular analysis of interleukin-10 gene polymorphisms in patients with Behçet's disease. Immunology Letters 194, pages 56-61.
Crossref
Crossref
Mastaneh Mohammadi, Farhad Shahram, Hormoz Shams, Massoomeh Akhlaghi, Farimah Ashofteh & Fereydoun Davatchi. (2017) High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study. International Journal of Rheumatic Diseases 20:9, pages 1269-1276.
Crossref
Crossref
Hadise Kavandi, Alireza Khabbazi, Sousan Kolahi, Mehrzad Hajialilo, Farid Karkon Shayan & Mohammad Oliaei. (2016) Long-term efficacy and safety of interferon ?-2a therapy in severe refractory ophthalmic Behcet?s disease. Clinical Rheumatology 35:11, pages 2765-2769.
Crossref
Crossref
Mahdi Vojdanian, Seyedeh Tahereh Faezi, Alan Tennant, Ann W. Morgan, Pedram Paragomi, Mostafa Qorbani, Maryam Mattaji & Fereydoun Davatchi. (2014) Validity and reliability of the Persian version of Behçet’s disease quality-of-life (BD-QoL) questionnaire: a cross-cultural adaptation. Rheumatology International 35:4, pages 677-684.
Crossref
Crossref
Alireza Khabbazi, Nadereh Rashtchizadeh, Amir Ghorbanihaghjo, Mehrzad Hajialiloo, Mortasa Ghojazadeh, Ramin Taei & Sousan Kolahi. (2014) The status of serum vitamin D in patients with active Behcet's disease compared with controls. International Journal of Rheumatic Diseases 17:4, pages 430-434.
Crossref
Crossref
Taraneh Dormohammadi Toosi, Farhad Shahram, S. Zahra Ghodsi, Abdolhadi Nadji, Arash Tehrani Banihashemi, Seyyedeh Roghieh Larimi & Fereydoun Davatchi. (2014) Iron deficiency state in resistant oral aphthosis of Behcet's disease. International Journal of Rheumatic Diseases 17:4, pages 425-429.
Crossref
Crossref
Gulen Hatemi, Peter A. Merkel, Vedat Hamuryudan, Maarten Boers, Haner Direskeneli, Sibel Z. Aydin & Hasan Yazici. (2014) Outcome Measures Used in Clinical Trials for Behçet Syndrome: A Systematic Review. The Journal of Rheumatology 41:3, pages 599-612.
Crossref
Crossref
Mehmet Melikoglu & Zeynep Topkarci. (2014) Is there a relation between clinical disease activity and acute phase response in Behcet's disease?. International Journal of Dermatology 53:2, pages 250-254.
Crossref
Crossref
Dae-Jun KimSeung-Ye BaekMi-Kyung ParkKyung-Su ParkJae Ho LeeSung-Hwan ParkHo-Youn KimSeung-Ki Kwok. (2013) Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease. Journal of Korean Medical Science 28:8, pages 1145.
Crossref
Crossref
Fereydoun Davatchi, Bahar Sadeghi Abdollahi, Arash Tehrani Banihashemi, Farhad Shahram, Abdolhadi Nadji, Hormoz Shams & Cheyda Chams-Davatchi. (2009) Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial. Modern Rheumatology 19:5, pages 542-549.
Crossref
Crossref